VRDN (STOCKS)
Viridian Therapeutics, Inc. Common Stock
$14.850000
-0.100000 (-0.67%)
Prev close: $14.950000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Stephen Frank Mahoney
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,511.64M
- Employees
- 143
- P/E (TTM)
- -3.89
- P/B (TTM)
- 2.58
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
9
Strong Buy
13
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.08 | $-1.09 | +0.0105 | +0.96% |
|
Sep 2025 (Q3)
|
$-0.34 | $-1.10 | +0.7644 | +69.21% |
|
Jun 2025 (Q2)
|
$-1.00 | $-1.03 | +0.0296 | +2.87% |
|
Mar 2025 (Q1)
|
$-0.87 | $-0.99 | +0.1164 | +11.80% |
Financial Statements
| Revenues | $70.85M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $434.24M |
| Nonoperating Income/Loss | $20.79M |
| Operating Expenses | $434.24M |
| Selling, General, and Administrative Expenses | $95.32M |
| Other Operating Expenses | $338.93M |
| Operating Income/Loss | -$363.40M |
| Income/Loss From Continuing Operations After Tax | -$342.60M |
| Income/Loss From Continuing Operations Before Tax | $70.85M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$342.60M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$342.60M |
| Net Income/Loss Available To Common Stockholders, Basic | -$342.60M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Assets | $899.42M |
| Current Assets | $894.23M |
| Cash | $874.70M |
| Other Current Assets | $19.53M |
| Noncurrent Assets | $5.19M |
| Fixed Assets | $1.23M |
| Other Non-current Assets | $3.96M |
| Liabilities | $177.25M |
| Current Liabilities | $70.70M |
| Accounts Payable | $8.68M |
| Wages | $19.66M |
| Other Current Liabilities | $42.36M |
| Noncurrent Liabilities | $106.56M |
| Equity | $722.17M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $722.17M |
| Liabilities And Equity | $899.42M |
| Net Cash Flow From Operating Activities | -$276.39M |
| Net Cash Flow From Operating Activities, Continuing | -$276.39M |
| Net Cash Flow From Investing Activities | -$37.56M |
| Net Cash Flow From Investing Activities, Continuing | -$37.56M |
| Net Cash Flow From Financing Activities | $426.74M |
| Net Cash Flow From Financing Activities, Continuing | $426.74M |
| Net Cash Flow | $112.79M |
| Net Cash Flow, Continuing | $112.79M |
| Comprehensive Income/Loss | -$342.14M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$342.14M |
| Other Comprehensive Income/Loss | -$342.14M |
| Other Comprehensive Income/Loss Attributable To Parent | $457.00K |